Costs of Integrated Mass Drug Administration for Neglected Tropical Diseases in Haiti
Identifieur interne : 002C14 ( Pmc/Corpus ); précédent : 002C13; suivant : 002C15Costs of Integrated Mass Drug Administration for Neglected Tropical Diseases in Haiti
Auteurs : Ann S. Goldman ; Molly A. Brady ; Abdel Direny ; Luccene Desir ; Roland Oscard ; Jean-Francois Vely ; Mary Linehan ; Margaret BakerSource :
- The American Journal of Tropical Medicine and Hygiene [ 0002-9637 ] ; 2011.
Abstract
We conducted a cost analysis of Haiti's Ministry of Public Health and Population neglected tropical disease program, Projet des Maladies Tropicales Negligées and collected data for 9 of 55 communes participating in the May 2008–April 2009 mass drug administration (MDA). The Projet des Maladies Tropicales Negligées Program partnered with IMA World Health and Hôpital Ste. Croix to implement MDA for treatment of lymphatic filariasis and soil-transmitted helminthiasis by using once a year treatment with albendazole and diethylcarbamazine in a population of approximately 8 million persons. Methods included analyzing partner financial records and conducting retrospective surveys of personnel. In the nine communes, 633,261 persons were treated at a cost of U.S. $0.64 per person, which included the cost of donated drugs, and at a cost of U.S. $0.42 per person treated, when excluding donated drug costs. The MDA for lymphatic filariasis in Haiti began in 2000, with the treatment of 105,750 persons at a cost per person of U.S. $2.23. The decrease in cost per person treated is the result of cumulative implementation experience and economies of scale.
Url:
DOI: 10.4269/ajtmh.2011.10-0635
PubMed: 22049035
PubMed Central: 3205627
Links to Exploration step
PMC:3205627Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Costs of Integrated Mass Drug Administration for Neglected Tropical Diseases in Haiti</title><author><name sortKey="Goldman, Ann S" sort="Goldman, Ann S" uniqKey="Goldman A" first="Ann S." last="Goldman">Ann S. Goldman</name></author><author><name sortKey="Brady, Molly A" sort="Brady, Molly A" uniqKey="Brady M" first="Molly A." last="Brady">Molly A. Brady</name></author><author><name sortKey="Direny, Abdel" sort="Direny, Abdel" uniqKey="Direny A" first="Abdel" last="Direny">Abdel Direny</name></author><author><name sortKey="Desir, Luccene" sort="Desir, Luccene" uniqKey="Desir L" first="Luccene" last="Desir">Luccene Desir</name></author><author><name sortKey="Oscard, Roland" sort="Oscard, Roland" uniqKey="Oscard R" first="Roland" last="Oscard">Roland Oscard</name></author><author><name sortKey="Vely, Jean Francois" sort="Vely, Jean Francois" uniqKey="Vely J" first="Jean-Francois" last="Vely">Jean-Francois Vely</name></author><author><name sortKey="Linehan, Mary" sort="Linehan, Mary" uniqKey="Linehan M" first="Mary" last="Linehan">Mary Linehan</name></author><author><name sortKey="Baker, Margaret" sort="Baker, Margaret" uniqKey="Baker M" first="Margaret" last="Baker">Margaret Baker</name></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">22049035</idno><idno type="pmc">3205627</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3205627</idno><idno type="RBID">PMC:3205627</idno><idno type="doi">10.4269/ajtmh.2011.10-0635</idno><date when="2011">2011</date><idno type="wicri:Area/Pmc/Corpus">002C14</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">002C14</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Costs of Integrated Mass Drug Administration for Neglected Tropical Diseases in Haiti</title><author><name sortKey="Goldman, Ann S" sort="Goldman, Ann S" uniqKey="Goldman A" first="Ann S." last="Goldman">Ann S. Goldman</name></author><author><name sortKey="Brady, Molly A" sort="Brady, Molly A" uniqKey="Brady M" first="Molly A." last="Brady">Molly A. Brady</name></author><author><name sortKey="Direny, Abdel" sort="Direny, Abdel" uniqKey="Direny A" first="Abdel" last="Direny">Abdel Direny</name></author><author><name sortKey="Desir, Luccene" sort="Desir, Luccene" uniqKey="Desir L" first="Luccene" last="Desir">Luccene Desir</name></author><author><name sortKey="Oscard, Roland" sort="Oscard, Roland" uniqKey="Oscard R" first="Roland" last="Oscard">Roland Oscard</name></author><author><name sortKey="Vely, Jean Francois" sort="Vely, Jean Francois" uniqKey="Vely J" first="Jean-Francois" last="Vely">Jean-Francois Vely</name></author><author><name sortKey="Linehan, Mary" sort="Linehan, Mary" uniqKey="Linehan M" first="Mary" last="Linehan">Mary Linehan</name></author><author><name sortKey="Baker, Margaret" sort="Baker, Margaret" uniqKey="Baker M" first="Margaret" last="Baker">Margaret Baker</name></author></analytic><series><title level="j">The American Journal of Tropical Medicine and Hygiene</title><idno type="ISSN">0002-9637</idno><idno type="eISSN">1476-1645</idno><imprint><date when="2011">2011</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>We conducted a cost analysis of Haiti's Ministry of Public Health and Population neglected tropical disease program, Projet des Maladies Tropicales Negligées and collected data for 9 of 55 communes participating in the May 2008–April 2009 mass drug administration (MDA). The Projet des Maladies Tropicales Negligées Program partnered with IMA World Health and Hôpital Ste. Croix to implement MDA for treatment of lymphatic filariasis and soil-transmitted helminthiasis by using once a year treatment with albendazole and diethylcarbamazine in a population of approximately 8 million persons. Methods included analyzing partner financial records and conducting retrospective surveys of personnel. In the nine communes, 633,261 persons were treated at a cost of U.S. $0.64 per person, which included the cost of donated drugs, and at a cost of U.S. $0.42 per person treated, when excluding donated drug costs. The MDA for lymphatic filariasis in Haiti began in 2000, with the treatment of 105,750 persons at a cost per person of U.S. $2.23. The decrease in cost per person treated is the result of cumulative implementation experience and economies of scale.</p></div></front></TEI><pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Am J Trop Med Hyg</journal-id><journal-id journal-id-type="publisher-id">tpmd</journal-id><journal-title-group><journal-title>The American Journal of Tropical Medicine and Hygiene</journal-title></journal-title-group><issn pub-type="ppub">0002-9637</issn><issn pub-type="epub">1476-1645</issn><publisher><publisher-name>The American Society of Tropical Medicine and Hygiene</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">22049035</article-id><article-id pub-id-type="pmc">3205627</article-id><article-id pub-id-type="doi">10.4269/ajtmh.2011.10-0635</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>Costs of Integrated Mass Drug Administration for Neglected Tropical Diseases in Haiti</article-title><alt-title alt-title-type="left-running-head">GOLDMAN AND OTHERS</alt-title><alt-title alt-title-type="left-running-head">NEGLECTED TROPICAL DISEASE PROGRAM COSTS IN HAITI</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Goldman</surname><given-names>Ann S.</given-names></name><xref ref-type="corresp" rid="COR1">*</xref></contrib><contrib contrib-type="author"><name><surname>Brady</surname><given-names>Molly A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Direny</surname><given-names>Abdel</given-names></name></contrib><contrib contrib-type="author"><name><surname>Desir</surname><given-names>Luccene</given-names></name></contrib><contrib contrib-type="author"><name><surname>Oscard</surname><given-names>Roland</given-names></name></contrib><contrib contrib-type="author"><name><surname>Vely</surname><given-names>Jean-Francois</given-names></name><xref ref-type="corresp" rid="COR2">†</xref></contrib><contrib contrib-type="author"><name><surname>Linehan</surname><given-names>Mary</given-names></name></contrib><contrib contrib-type="author"><name><surname>Baker</surname><given-names>Margaret</given-names></name></contrib></contrib-group><aff id="AFF1">The George Washington University School of Public Health and Health Services, Washington, District of Columbia; RTI International, Washington, District of Columbia; IMA World Health, Port-au-Prince, Haiti; Hôpital Ste. Croix, Leogane, Haiti; University of Notre Dame, South Bend, Indiana; Ministère de la Santé, Port-au-Prince, Haiti; Georgetown University, Washington, District of Columbia</aff><author-notes><corresp id="COR1">*Address correspondence to Ann S. Goldman, The George Washington University School of Public Health and Health Services, 2100 West Pennsylvania Avenue, NW, 8th Floor, Washington, DC 20037. E-mail: <email>sphasg@gwumc.edu</email></corresp><corresp id="COR2">†Deceased.</corresp></author-notes><pub-date pub-type="ppub"><day>01</day><month>11</month><year>2011</year></pub-date><volume>85</volume><issue>5</issue><fpage>826</fpage><lpage>833</lpage><history><date date-type="received"><day>09</day><month>11</month><year>2010</year></date><date date-type="accepted"><day>06</day><month>7</month><year>2011</year></date></history><permissions><copyright-statement>©The American Society of Tropical Medicine and Hygiene</copyright-statement><copyright-year>2011</copyright-year></permissions><abstract><p>We conducted a cost analysis of Haiti's Ministry of Public Health and Population neglected tropical disease program, Projet des Maladies Tropicales Negligées and collected data for 9 of 55 communes participating in the May 2008–April 2009 mass drug administration (MDA). The Projet des Maladies Tropicales Negligées Program partnered with IMA World Health and Hôpital Ste. Croix to implement MDA for treatment of lymphatic filariasis and soil-transmitted helminthiasis by using once a year treatment with albendazole and diethylcarbamazine in a population of approximately 8 million persons. Methods included analyzing partner financial records and conducting retrospective surveys of personnel. In the nine communes, 633,261 persons were treated at a cost of U.S. $0.64 per person, which included the cost of donated drugs, and at a cost of U.S. $0.42 per person treated, when excluding donated drug costs. The MDA for lymphatic filariasis in Haiti began in 2000, with the treatment of 105,750 persons at a cost per person of U.S. $2.23. The decrease in cost per person treated is the result of cumulative implementation experience and economies of scale.</p></abstract></article-meta><notes notes-type="disclaimer"><p>Disclaimer: The contents of this article are the responsibility of the authors and do not necessarily reflect the views of the US Agency for International Development or the United States Government.</p></notes></front></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002C14 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 002C14 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé= PMC:3205627
|texte= Costs of Integrated Mass Drug Administration for Neglected Tropical Diseases in Haiti
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i -Sk "pubmed:22049035" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |